source
- Clene Nanomedicine partners with Veristat to speed data analysis for ALS drug FDA filingClene Nanomedicine has entered a partnership with clinical research organization Veristat. Under the agreement, Veristat will apply its biostatistics platform to speed the generation and analysis…
- FDA issues warning letters to three Chinese API makers over record refusals and quality oversight lapsesThe FDA sent warning letters to three active pharmaceutical ingredient manufacturers based in China. Two firms were cited for refusing the agency's requests for records, while the third was found…